Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05251233 · ClinicalTrials.gov registry record · Phase 2
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
A Phase 2 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 2
- Development phase
- 56
- Enrollment target
NCT05251233 is a Phase 2 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 56 participants.
The verdict
NCT05251233, a Phase 2 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively determine the effects of administering proton pump inhibitors (PPIs) following pancreaticoduodenectomy on postoperative outcomes. The findings of this study will help in avoiding the widespread use of PPIs during the immediate postoperative period following pancreatic surgery.
Interventions
- DRUG Placebo
- DRUG Pantoprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2024-06-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05251233
The ClinicalTrials.gov registry entry for NCT05251233 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05251233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05251233 about?
NCT05251233 is a clinical study titled "Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy". The purpose of this study is to prospectively determine the effects of administering proton pump inhibitors (PPIs) following pancreaticoduodenectomy on postoperative outcomes. The findings of this study will help in avoiding the widespread use of PPIs during the immediate postoperative period follow...
What is the current status of trial NCT05251233?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 56 participants. The study started on 2022-04-21. Estimated completion is 2024-06-29.
What interventions are being tested in trial NCT05251233?
The interventions under investigation include: Placebo (DRUG), Pantoprazole (DRUG).
Who is sponsoring clinical trial NCT05251233?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.